ChemPartner attended the EFMC Medicinal Chemistry 2026 conference in Basel.

ChemPartner is a global contract research organization (CRO) trusted by pharmaceutical and biotech companies for seamless, scalable support from discovery through IND. With scientific expertise spanning discovery biology, pharmacology, DMPK, bioanalysis, and chemistry, we provide fully integrated solutions tailored to the needs of innovative drug developers worldwide. We support projects across all major therapeutic modalities, including small molecules, biologics, antibody-drug conjugates (ADCs), and cell and gene therapies. Our scientists are deeply collaborative—working as an extension of your team to design and execute studies that deliver meaningful, decision-driving data. Whether you are a startup advancing your first candidate or an established company looking to scale, ChemPartner offers the scientific partnership, flexibility, and operational excellence needed to accelerate your path to the clinic. Capabilities Include: Discovery Biology & Mechanism-of-Action Studies In Vitro & In Vivo Pharmacology DMPK & Bioanalysis Medicinal & Synthetic Chemistry Biologics Discovery (including B-cell cloning, hybridoma, and phage display) Oncology, Immunology, and Infectious Disease Models IND-Enabling Support With a strong track record of scientific innovation and global delivery, ChemPartner is committed to helping our partners solve complex R&D challenges.